522 related articles for article (PubMed ID: 29463044)
1. The Role of the Estrogen Pathway in the Tumor Microenvironment.
Rothenberger NJ; Somasundaram A; Stabile LP
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463044
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Estrogen in the Tumor Microenvironment.
Somasundaram A; Rothenberger NJ; Stabile LP
Adv Exp Med Biol; 2020; 1277():33-52. PubMed ID: 33119863
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.
Nagpal N; Ahmad HM; Molparia B; Kulshreshtha R
Carcinogenesis; 2013 Aug; 34(8):1889-99. PubMed ID: 23542418
[TBL] [Abstract][Full Text] [Related]
4. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology.
Segovia-Mendoza M; Morales-Montor J
Front Immunol; 2019; 10():348. PubMed ID: 30881360
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor regulation of the immune microenvironment in breast cancer.
McGuinness C; Britt KL
J Steroid Biochem Mol Biol; 2024 Jun; 240():106517. PubMed ID: 38555985
[TBL] [Abstract][Full Text] [Related]
6. Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications.
Smida T; Bruno TC; Stabile LP
Front Oncol; 2020; 10():137. PubMed ID: 32133288
[TBL] [Abstract][Full Text] [Related]
7. Overcoming tumor-mediated immunosuppression.
Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
[TBL] [Abstract][Full Text] [Related]
8. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.
De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567
[TBL] [Abstract][Full Text] [Related]
9. Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer.
Kozieł MJ; Piastowska-Ciesielska AW
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834120
[TBL] [Abstract][Full Text] [Related]
10. Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.
Hayashi S; Yamaguchi Y
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):201-6. PubMed ID: 18424035
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics and immunotherapy: The current state of play.
Dunn J; Rao S
Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.
Chen W; Jiang J; Xia W; Huang J
J Immunol Res; 2017; 2017():1073947. PubMed ID: 28642882
[TBL] [Abstract][Full Text] [Related]
13. ILT4 functions as a potential checkpoint molecule for tumor immunotherapy.
Gao A; Sun Y; Peng G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):278-285. PubMed ID: 29649510
[TBL] [Abstract][Full Text] [Related]
14. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
Wu D
Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
[TBL] [Abstract][Full Text] [Related]
15. Translation of cancer immunotherapy from the bench to the bedside.
Guo Q; Huang F; Goncalves C; Del Rincón SV; Miller WH
Adv Cancer Res; 2019; 143():1-62. PubMed ID: 31202357
[TBL] [Abstract][Full Text] [Related]
16. Immune suppression and reversal of the suppressive tumor microenvironment.
Shimizu K; Iyoda T; Okada M; Yamasaki S; Fujii SI
Int Immunol; 2018 Sep; 30(10):445-454. PubMed ID: 29939325
[TBL] [Abstract][Full Text] [Related]
17. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
18. Immuno-oncology-101: overview of major concepts and translational perspectives.
Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
Marciscano AE; Madan RA
Curr Treat Options Oncol; 2018 Mar; 19(3):16. PubMed ID: 29520448
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer-related inflammation in the era of immunotherapy.
Nakamura K; Smyth MJ
Immunol Cell Biol; 2017 Apr; 95(4):325-332. PubMed ID: 27999432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
